US Approves First mRNA-Based Seasonal Flu Vaccine for Adults Aged 50 and Older
Washington: The Food and Drug Administration (FDA) has approved Moderna’s mFlusiva vaccine, marking it as the first seasonal influenza vaccine in the United States based on messenger RNA (mRNA) technology. This approval is specifically for adults aged…